Postoperative Pain Control in Total Shoulder Arthroplasty

• Status: Recruiting
• Trial end date: 2023-07-01
• Target enrollment: 0
• Participant gender: All

Summary

A double blind, prospective, randomized trial to evaluate postoperative pain, narcotic use, patient satisfaction, and function among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Scripps Clinic
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Patients undergoing primary shoulder arthroplasty or reverse shoulder arthroplasty

Exclusion Criteria:

• Patients under the age of 50 years

• Patients over the age of 85

• Patients undergoing a revision shoulder procedure

• Documented drug or alcohol abuse

• Active narcotic use within 3 months prior to surgery

• Neurological deficit

• Allergy to amide anesthetics

• Oxycodone intolerance

• Unable to take Celebrex

• Enrollment in another clinical trial

• Comorbidity that is contraindicated with the administration of an interscalene block

• Cognitive or mental health status that interferes with study